These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 24811015)
1. Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report. Sokol KC; Ghazi A; Kelly BC; Grant JA J Allergy Clin Immunol Pract; 2014; 2(3):266-70. PubMed ID: 24811015 [TBL] [Abstract][Full Text] [Related]
5. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting. Palgan K; Bartuzi Z; Gotz-Zbikowska M Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy. Paraskevopoulos G; Sifnaios E; Christodoulopoulos K; Mantopoulou F; Papakonstantis M; Sabaziotis D Eur Ann Allergy Clin Immunol; 2013 Apr; 45(2):52-5. PubMed ID: 23821833 [TBL] [Abstract][Full Text] [Related]
14. Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis. Kibsgaard L; Skjold T; Deleuran M; Vestergaard C Acta Derm Venereol; 2014 May; 94(3):363-4. PubMed ID: 24162824 [No Abstract] [Full Text] [Related]
15. Immunotherapy in food allergy: towards new strategies. Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336 [TBL] [Abstract][Full Text] [Related]
16. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology. Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583 [TBL] [Abstract][Full Text] [Related]
17. Omalizumab in chronic urticaria: a retrospective series of 15 cases. Armengot-Carbo M; Velasco-Pastor M; Rodrigo-Nicolas B; Pont-Sanjuan V; Quecedo-Estebanez E; Gimeno-Carpio E Dermatol Ther; 2013; 26(3):257-9. PubMed ID: 23742285 [TBL] [Abstract][Full Text] [Related]
19. Extraordinary response to omalizumab in a child with severe chronic urticaria. Asero R; Casalone R; Iemoli E Eur Ann Allergy Clin Immunol; 2014 Jan; 46(1):41-2. PubMed ID: 24702874 [TBL] [Abstract][Full Text] [Related]